-
Je něco špatně v tomto záznamu ?
Risk Stratification by Cross-Classification of Central and Brachial Systolic Blood Pressure
YB. Cheng, L. Thijs, LS. Aparicio, QF. Huang, FF. Wei, YL. Yu, J. Barochiner, CS. Sheng, WY. Yang, TJ. Niiranen, J. Boggia, ZY. Zhang, K. Stolarz-Skrzypek, N. Gilis-Malinowska, V. Tikhonoff, W. Wojciechowska, E. Casiglia, K. Narkiewicz, J....
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, metaanalýza, práce podpořená grantem
NLK
Free Medical Journals
od 1979 do Před 1 rokem
Open Access Digital Library
od 1979-01-01
Open Access Digital Library
od 1979-01-01
- MeSH
- arteria brachialis MeSH
- hodnocení rizik MeSH
- hypertenze * diagnóza epidemiologie MeSH
- krevní tlak fyziologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- měření krevního tlaku * MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- metaanalýza MeSH
- práce podpořená grantem MeSH
BACKGROUND: Whether cardiovascular risk is more tightly associated with central (cSBP) than brachial (bSBP) systolic pressure remains debated, because of their close correlation and uncertain thresholds to differentiate cSBP into normotension versus hypertension. METHODS: In a person-level meta-analysis of the International Database of Central Arterial Properties for Risk Stratification (n=5576; 54.1% women; mean age 54.2 years), outcome-driven thresholds for cSBP were determined and whether the cross-classification of cSBP and bSBP improved risk stratification was explored. cSBP was tonometrically estimated from the radial pulse wave using SphygmoCor software. RESULTS: Over 4.1 years (median), 255 composite cardiovascular end points occurred. In multivariable bootstrapped analyses, cSBP thresholds (in mm Hg) of 110.5 (95% CI, 109.1-111.8), 120.2 (119.4-121.0), 130.0 (129.6-130.3), and 149.5 (148.4-150.5) generated 5-year cardiovascular risks equivalent to the American College of Cardiology/American Heart Association bSBP thresholds of 120, 130, 140, and 160. Applying 120/130 mm Hg as cSBP/bSBP thresholds delineated concordant central and brachial normotension (43.1%) and hypertension (48.2%) versus isolated brachial hypertension (5.0%) and isolated central hypertension (3.7%). With concordant normotension as reference, the multivariable hazard ratios for the cardiovascular end point were 1.30 (95% CI, 0.58-2.94) for isolated brachial hypertension, 2.28 (1.21-4.30) for isolated central hypertension, and 2.02 (1.41-2.91) for concordant hypertension. The increased cardiovascular risk associated with isolated central and concordant hypertension was paralleled by cerebrovascular end points with hazard ratios of 3.71 (1.37-10.06) and 2.60 (1.35-5.00), respectively. CONCLUSIONS: Irrespective of the brachial blood pressure status, central hypertension increased cardiovascular and cerebrovascular risk indicating the importance of controlling central hypertension.
Biomedical Sciences Group Faculty of Medicine University of Leuven Belgium
Department of Cardiology Shanghai General Hospital Shanghai China
Department of Cardiology the 1st Affiliated Hospital of Sun Yat Sen University Guangzhou China
Department of Chronic Disease Prevention Finnish Institute for Health and Welfare Turku Finland
Department of Medicine TurkuUniversity Hospital and University of Turku
Department of Medicine University of Padua Italy
Faculty of Medicine Charles University Pilsen Czech Republic
Hypertension Unit Department of Hypertension and Diabetology Medical University of Gdańsk Poland
Research Institute Alliance for the Promotion of Preventive Medicine Mechelen Belgium
Servicio de Clínica Médica Sección Hipertensión Arterial Hospital Italiano de Buenos Aires Argentina
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22018571
- 003
- CZ-PrNML
- 005
- 20220804134854.0
- 007
- ta
- 008
- 220720s2022 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1161/HYPERTENSIONAHA.121.18773 $2 doi
- 035 __
- $a (PubMed)35240865
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Cheng, Yi-Bang $u Department of Cardiovascular Medicine, Shanghai Key Laboratory of Hypertension, Shanghai Institute of Hypertension, State Key Laboratory of Medical Genomics, National Research Centre for Translational Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China (Y.-B.C., Q.-F.H., C.-S.S., J.-G.W., Y.L.) $1 https://orcid.org/0000000238223504
- 245 10
- $a Risk Stratification by Cross-Classification of Central and Brachial Systolic Blood Pressure / $c YB. Cheng, L. Thijs, LS. Aparicio, QF. Huang, FF. Wei, YL. Yu, J. Barochiner, CS. Sheng, WY. Yang, TJ. Niiranen, J. Boggia, ZY. Zhang, K. Stolarz-Skrzypek, N. Gilis-Malinowska, V. Tikhonoff, W. Wojciechowska, E. Casiglia, K. Narkiewicz, J. Filipovský, K. Kawecka-Jaszcz, JG. Wang, Y. Li, JA. Staessen, International Database of Central Arterial Properties for Risk Stratification (IDCARS) Investigators
- 520 9_
- $a BACKGROUND: Whether cardiovascular risk is more tightly associated with central (cSBP) than brachial (bSBP) systolic pressure remains debated, because of their close correlation and uncertain thresholds to differentiate cSBP into normotension versus hypertension. METHODS: In a person-level meta-analysis of the International Database of Central Arterial Properties for Risk Stratification (n=5576; 54.1% women; mean age 54.2 years), outcome-driven thresholds for cSBP were determined and whether the cross-classification of cSBP and bSBP improved risk stratification was explored. cSBP was tonometrically estimated from the radial pulse wave using SphygmoCor software. RESULTS: Over 4.1 years (median), 255 composite cardiovascular end points occurred. In multivariable bootstrapped analyses, cSBP thresholds (in mm Hg) of 110.5 (95% CI, 109.1-111.8), 120.2 (119.4-121.0), 130.0 (129.6-130.3), and 149.5 (148.4-150.5) generated 5-year cardiovascular risks equivalent to the American College of Cardiology/American Heart Association bSBP thresholds of 120, 130, 140, and 160. Applying 120/130 mm Hg as cSBP/bSBP thresholds delineated concordant central and brachial normotension (43.1%) and hypertension (48.2%) versus isolated brachial hypertension (5.0%) and isolated central hypertension (3.7%). With concordant normotension as reference, the multivariable hazard ratios for the cardiovascular end point were 1.30 (95% CI, 0.58-2.94) for isolated brachial hypertension, 2.28 (1.21-4.30) for isolated central hypertension, and 2.02 (1.41-2.91) for concordant hypertension. The increased cardiovascular risk associated with isolated central and concordant hypertension was paralleled by cerebrovascular end points with hazard ratios of 3.71 (1.37-10.06) and 2.60 (1.35-5.00), respectively. CONCLUSIONS: Irrespective of the brachial blood pressure status, central hypertension increased cardiovascular and cerebrovascular risk indicating the importance of controlling central hypertension.
- 650 _2
- $a krevní tlak $x fyziologie $7 D001794
- 650 12
- $a měření krevního tlaku $7 D001795
- 650 _2
- $a arteria brachialis $7 D001916
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a hypertenze $x diagnóza $x epidemiologie $7 D006973
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a hodnocení rizik $7 D018570
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a metaanalýza $7 D017418
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Thijs, Lutgarde $u Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (L.T., F.-F.W., Y.-L.Y., W.-Y.Y., Z.-Y.Z.) $1 https://orcid.org/0000000281082356
- 700 1_
- $a Aparicio, Lucas S $u Servicio de Clínica Médica, Sección Hipertensión Arterial, Hospital Italiano de Buenos Aires, Argentina (L.S.A., J.Ba.)
- 700 1_
- $a Huang, Qi-Fang $u Department of Cardiovascular Medicine, Shanghai Key Laboratory of Hypertension, Shanghai Institute of Hypertension, State Key Laboratory of Medical Genomics, National Research Centre for Translational Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China (Y.-B.C., Q.-F.H., C.-S.S., J.-G.W., Y.L.) $1 https://orcid.org/0000000297804237
- 700 1_
- $a Wei, Fang-Fei $u Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (L.T., F.-F.W., Y.-L.Y., W.-Y.Y., Z.-Y.Z.) $u Department of Cardiology, the First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China (F.-F.W.) $1 https://orcid.org/0000000245732403
- 700 1_
- $a Yu, Yu-Ling $u Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (L.T., F.-F.W., Y.-L.Y., W.-Y.Y., Z.-Y.Z.) $u Research Unit Environment and Health, KU Leuven Department of Public Health and Primary Care, University of Leuven, Belgium (Y.-L.Y) $1 https://orcid.org/0000000282553770
- 700 1_
- $a Barochiner, Jessica $u Servicio de Clínica Médica, Sección Hipertensión Arterial, Hospital Italiano de Buenos Aires, Argentina (L.S.A., J.Ba.) $1 https://orcid.org/0000000221769762
- 700 1_
- $a Sheng, Chang-Sheng $u Department of Cardiovascular Medicine, Shanghai Key Laboratory of Hypertension, Shanghai Institute of Hypertension, State Key Laboratory of Medical Genomics, National Research Centre for Translational Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China (Y.-B.C., Q.-F.H., C.-S.S., J.-G.W., Y.L.)
- 700 1_
- $a Yang, Wen-Yi $u Department of Cardiology, Shanghai General Hospital, Shanghai, China (W.-Y.Y.) $1 https://orcid.org/0000000312790866
- 700 1_
- $a Niiranen, Teemu J $u Department of Chronic Disease Prevention, Finnish Institute for Health and Welfare, Turku, Finland (T.J.N.) $u Department of Medicine, TurkuUniversity Hospital and University of Turku (T.J.N.) $1 https://orcid.org/0000000273947487
- 700 1_
- $a Boggia, José $u Centro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay (J.Bo.) $1 https://orcid.org/0000000215648534
- 700 1_
- $a Zhang, Zhen-Yu $u Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (L.T., F.-F.W., Y.-L.Y., W.-Y.Y., Z.-Y.Z.) $1 https://orcid.org/0000000237857417
- 700 1_
- $a Stolarz-Skrzypek, Katarzyna $u First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Kraków, Poland (K.S.-S., W.W., K.K.-J.)
- 700 1_
- $a Gilis-Malinowska, Natasza $u Hypertension Unit, Department of Hypertension and Diabetology, Medical University of Gdańsk, Poland (N.G.-M., K.N.)
- 700 1_
- $a Tikhonoff, Valérie $u Department of Medicine, University of Padua, Italy (V.T., E.C.) $1 https://orcid.org/0000000178460101
- 700 1_
- $a Wojciechowska, Wiktoria $u First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Kraków, Poland (K.S.-S., W.W., K.K.-J.) $1 https://orcid.org/0000000330753508
- 700 1_
- $a Casiglia, Edoardo $u Department of Medicine, University of Padua, Italy (V.T., E.C.) $1 https://orcid.org/0000000200033289
- 700 1_
- $a Narkiewicz, Krzysztof $u Hypertension Unit, Department of Hypertension and Diabetology, Medical University of Gdańsk, Poland (N.G.-M., K.N.) $1 https://orcid.org/0000000159495018
- 700 1_
- $a Filipovský, Jan $u Faculty of Medicine, Charles University, Pilsen, Czech Republic (J.F.) $1 https://orcid.org/0000000215351263
- 700 1_
- $a Kawecka-Jaszcz, Kalina $u First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Kraków, Poland (K.S.-S., W.W., K.K.-J.)
- 700 1_
- $a Wang, Ji-Guang $u Department of Cardiovascular Medicine, Shanghai Key Laboratory of Hypertension, Shanghai Institute of Hypertension, State Key Laboratory of Medical Genomics, National Research Centre for Translational Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China (Y.-B.C., Q.-F.H., C.-S.S., J.-G.W., Y.L.) $1 https://orcid.org/0000000185111524
- 700 1_
- $a Li, Yan $u Department of Cardiovascular Medicine, Shanghai Key Laboratory of Hypertension, Shanghai Institute of Hypertension, State Key Laboratory of Medical Genomics, National Research Centre for Translational Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China (Y.-B.C., Q.-F.H., C.-S.S., J.-G.W., Y.L.) $1 https://orcid.org/0000000258255968
- 700 1_
- $a Staessen, Jan A $u Research Institute Alliance for the Promotion of Preventive Medicine, Mechelen, Belgium (J.A.S.) $u Biomedical Sciences Group, Faculty of Medicine, University of Leuven, Belgium (J.A.S.) $1 https://orcid.org/0000000230261637 $7 xx0254041
- 710 2_
- $a International Database of Central Arterial Properties for Risk Stratification (IDCARS) Investigators
- 773 0_
- $w MED00002089 $t Hypertension (Dallas, Tex. : 1979) $x 1524-4563 $g Roč. 79, č. 5 (2022), s. 1101-1111
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35240865 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220720 $b ABA008
- 991 __
- $a 20220804134848 $b ABA008
- 999 __
- $a ok $b bmc $g 1822260 $s 1169814
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 79 $c 5 $d 1101-1111 $e 20220304 $i 1524-4563 $m Hypertension $n Hypertension $x MED00002089
- LZP __
- $a Pubmed-20220720
